Latest in Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
Sort by
3,400 items
-
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.Business - CNBC - 1 hour ago -
Eli Lilly’s stock dives as Mounjaro and Zepbound sales miss, but Citi says buy
Eli Lilly’s stock heads for biggest selloff in more than 4 years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.Business - MarketWatch - 48 minutes ago -
Honeywell’s stock falls as sales miss and lowered guidance offsets profit beat
Honeywell International Inc.’s stock fell 2.5% early Thursday, after the aerospace and technology company missed third-quarter sales estimates and lowered its guidance, offsetting a profit beat.Business - MarketWatch - 6 days ago -
Biogen’s stock pops after earnings top estimates and company raises guidance
“We continue to see momentum with ongoing product launches and we are increasingly excited about the potential of our pipeline,” the company’s CEO said.Business - MarketWatch - 3 hours ago -
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company's multiple sclerosis products.Business - CNBC - 2 hours ago -
Shares in weight-loss drugmaker Eli Lilly tumble on disappointing sales
US group revises down upper end of full-year revenue estimatesBusiness - Financial Times - 3 hours ago -
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.Business - CNBC - October 15 -
Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.Top stories - NBC News - October 16 -
CVS cuts outlook yet again — while swapping out CEO for a company veteran
“The shift in management is not surprising as the company looks to level set its operations and strategically position itself for future growth,” analyst said.Business - MarketWatch - October 18 -
Centene’s stock soars 11% after earnings sweep past estimates and company backs guidance
Chief Executive Sarah M. London said the company had navigated a “dynamic landscape” in the quarter amid turmoil in the Medicaid business.Business - MarketWatch - 5 days ago -
Reddit’s stock soars after social-media platform turns a profit, beats Q3 sales and earnings estimates
Reddit said Tuesday that it turned a profit in its third quarter — a first for the social-media platform since becoming a public company earlier this year.Business - MarketWatch - 15 hours ago -
Elevance Health’s stock slumps 13% as profit dented by ‘unprecedented’ Medicaid challenges
Elevance Health Inc.’s stock tumbled 13% Thursday and weighed on rivals after the health insurer’s third-quarter profit fell short of estimates amid ”unprecedented” challenges in the Medicaid ...Business - MarketWatch - October 17 -
Hyundai Motor Net Profit Fell in Third Quarter, Missing Estimates
The South Korean carmaker said wholesale car sales fell 3.2% globally as vehicle demand remained sluggish in most major markets, while North America remained a bright spot.Business - The Wall Street Journal - 6 days ago -
Biotech stock tumbles after unexplained 1,446% gain
Bright Minds Biosciences, which until this week had a lightly traded stock that traded at just over $1, tumbled in premarket trade on Wednesday following a meteoric rise.Business - MarketWatch - October 16 -
Royal Caribbean CEO: Americans are ‘wealthier than ever’ and love to travel
Royal Caribbean’s stock pulls back from a record after revenue, profit outlook for the current quarter disappoint.Business - MarketWatch - Yesterday -
Novartis Lifts Guidance Again After Key Drugs Help Results
The pharmaceutical giant raised its full-year guidance for the third time this year after higher third-quarter profit and sales topped analysts’ expectations, boosted by revenue from its key drugs.Business - The Wall Street Journal - Yesterday -
ASML’s stock tumbles after microchip equipment maker warns of slower recovery
ASML Holding, the Dutch microchip-equipment maker, saw its stock slide after saying the market recovery for semiconductors will take longer than expected.Business - MarketWatch - October 15 -
Phunware’s stock tumbles more than 35% after CEO retires
Shares of Phunware Inc. were down more than 35% after the retirement of Chief Executive Mike Snavely from the mobile-advertising company.Business - MarketWatch - 5 days ago -
Lloyds Banking Beats Views as U.K. Borrowers Remain Resilient
The U.K.’s largest mortgage provider confirmed its full-year guidance after pretax profit fell by less than expected on lighter impairments for bad loans as British borrowers remained resilient ...Business - The Wall Street Journal - October 23 -
Telia Raises Guidance After Key Metric Profit Beat
The Swedish telecommunications operator said it expected stronger growth momentum in the fourth quarter of the year and raised its guidance as it reported a slight beat on adjusted underlying ...Business - The Wall Street Journal - 6 days ago -
NatWest Lifts Guidance Again After Quarterly Profit Beat
The U.K. high-street bank raised its revenue and profit outlook for the second time this year after its third-quarter results topped market expectations, lifting shares to an over 13-year high.Business - The Wall Street Journal - 5 days ago -
Winnebago’s stock rocked by a big profit miss, due to ‘sluggish’ retail demand
Winnebago’s stock sinks after a big profit miss for its fiscal fourth quarter, which offset a revenue beat.Business - MarketWatch - October 23 -
Caterpillar’s stock falls as weak equipment sales lead to a rare profit miss
Caterpillar’s stock fell after a rare profit miss, while revenue was below expectations for a fourth straight quarter.Business - MarketWatch - 2 minutes ago -
AutoNation’s stock falls after earnings fall short of estimates
The new- and used-car retailer is still feeling the impact of a recent dealership-software outage.Business - MarketWatch - 4 days ago -
Snap shares jump 10% on profit beat, stock buyback
Snap reported third-quarter results on Tuesday that beat on the top and bottom lines, but the company issued light fourth-quarter guidance.Business - CNBC - 18 hours ago -
Pfizer’s earnings crush estimates as company raises guidance
Drug company Pfizer saw strong growth for its heart-disease drugs and migraine treatment.Business - MarketWatch - Yesterday -
Morgan Stanley shares pop 7% after beating estimates for third-quarter profit and revenue
Morgan Stanley has several tail winds in its favor, from high stock values to a rebound in investment banking and strong trading activity.Business - CNBC - October 16 -
Standard Chartered lifts income guidance again after beating third-quarter profit forecasts
The lender, which derives most of its revenue from Asia, saw pre-tax profit jump of 37% from the $1.32 billion posted a year ago.Business - CNBC - 2 hours ago -
Volvo Cars says it will not support Northvolt as it slashes sales guidance
Swedish group says it will not invest in its battery group partner amid softening demand for vehicles in key marketsBusiness - Financial Times - October 23 -
Nvidia and Apple supplier TSMC shares pop after quarterly profit soars on AI demand
TSMC, the world’s largest producer of advanced chips, posted a 54% hike in third-quarter profit.Business - CNBC - October 18